AR020124A1 - DERIVATIVES OF PIPERAZINONE, A PROCEDURE FOR THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT - Google Patents
DERIVATIVES OF PIPERAZINONE, A PROCEDURE FOR THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE A MEDICINAL PRODUCTInfo
- Publication number
- AR020124A1 AR020124A1 ARP990103925A ARP990103925A AR020124A1 AR 020124 A1 AR020124 A1 AR 020124A1 AR P990103925 A ARP990103925 A AR P990103925A AR P990103925 A ARP990103925 A AR P990103925A AR 020124 A1 AR020124 A1 AR 020124A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- derivatives
- piperazinone
- cooa
- hal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los nuevos derivados de la piperazinona de la formula (1), en donde: R1, R2 representan independientemente A, fenilo, naftilo o bifenilo nosustituido o mono, di- o trisustituido con R8, A, Ar, OH, OA, O(C(R3)2)n-Ar,-OAr,NH2, NHA, NA2, NO2, CN, Hal,N HCOA, NHCOAr, NHSO2A, NHSO2Ar, COOH,COOA, CONH2, CONHA, CONA2, CONHAr, COA, COAr, S(O)nA, S(O)nAr, SO2NH2, SO2NHA o SO2NA2, o un heterociclo saturado, insaturado o aromático de uno o dosnucleos que contiene de 1 a 4 átomos de N, O y/o S, que seencue ntra unido a través del N o C y que puede estar no sustituido o mono, di o trisustituidocon R8, A, Ar, OH, OA, OAr, NH2, NHA, NA2, NO2, CN, Hal, NHCOA, NHCOAr, NHSO2A, NHSO2Ar, COOH, COOA, CONH2, CONHA, CONA2, CONHAr, COA, COAr,S(O)nA,S(O)nAr, SO2NH 2, SO2NHA o SO2NA2 o carboniloxi, con la condicion de que el resto R8 debe estar presente al menos una vez en R1 o en R2, o también puedeaparecer una vez en cada uno de los restos R1 y R2; R3 representa H o A; representanindependientemente H, A, C(R 3)2)n-Ar, (C(R3)2)n-Het, (C(R3)2)n-COOR3,representa C(=NH)-NH2 no sustituido o también monosustituido con COA, CO-[C(R3)2]n-Ar, COOA, OH o con un grupo protector de amino convencional, orepresenta un grupo no sustituidode NH-C(=NH)-NH2, CON=C(NH2)2, formula (2); W representa -CO, -C(R3)2, X representa -(C(R3)2)n,-SO2, -CO-, -COO-, -CONR4-,y A, Ar, Ar, Het, Hal y n tienen los significados indicados en la reivindicacion 1, y también sus sales y solvatos, actuan comoinhibidores del factor decoagu lacion Xa y pueden ser empleados para la profilaxis y/o terapia de las enfermedades tromboembolicas. Un procedimiento para preparar losderivados de la piperazinona de formula (1), en el cual: a) se libera loscompuestos de uno de sus derivados funcio nales por tratamiento con un agentede solvolisis o hidrogenolisis, o b) se hace reaccionar un compuestos de formula (3), en donde: R1, R3, R4, R5, R6, R7 y W tienen los significadosindicados en lareivindicacion 1 y R8 representa formula (4) con un c ompuesto de formula (5): R2-X-L en donde: R2 y X tienen el significado indicado en laThe new piperazinone derivatives of the formula (1), wherein: R1, R2 independently represent A, phenyl, naphthyl or biphenyl substituted or mono, di- or trisubstituted with R8, A, Ar, OH, OA, O (C (R3) 2) n-Ar, -OAr, NH2, NHA, NA2, NO2, CN, Hal, N HCOA, NHCOAr, NHSO2A, NHSO2Ar, COOH, COOA, CONH2, CONHA, CONA2, CONHAr, COA, COAr, S (O) nA, S (O) nAr, SO2NH2, SO2NHA or SO2NA2, or a saturated, unsaturated or aromatic heterocycle of one or two nuclei containing from 1 to 4 atoms of N, O and / or S, which is attached to through N or C and which may be unsubstituted or mono, di or trisubstituted with R8, A, Ar, OH, OA, OAr, NH2, NHA, NA2, NO2, CN, Hal, NHCOA, NHCOAr, NHSO2A, NHSO2Ar, COOH , COOA, CONH2, CONHA, CONA2, CONHAr, COA, COAr, S (O) nA, S (O) nAr, SO2NH 2, SO2NHA or SO2NA2 or carbonyloxy, with the proviso that the rest R8 must be present at least one once in R1 or R2, or it can also appear once in each of the remains R1 and R2; R3 represents H or A; independently represent H, A, C (R 3) 2) n-Ar, (C (R3) 2) n-Het, (C (R3) 2) n-COOR3, represents C (= NH) -NH2 unsubstituted or also monosubstituted with COA, CO- [C (R3) 2] n-Ar, COOA, OH or with a conventional amino protecting group, or represents an unsubstituted group of NH-C (= NH) -NH2, CON = C (NH2) 2, formula (2); W represents -CO, -C (R3) 2, X represents - (C (R3) 2) n, -SO2, -CO-, -COO-, -CONR4-, and A, Ar, Ar, Het, Hal and n they have the meanings indicated in claim 1, and also their salts and solvates, act as inhibitors of decoding factor Xa and can be used for the prophylaxis and / or therapy of thromboembolic diseases. A process for preparing the derivatives of the piperazinone of formula (1), in which: a) the compounds of one of its functional derivatives are released by treatment with a solvolysis or hydrogenolysis agent, or b) a compound of formula (3) is reacted ), wherein: R1, R3, R4, R5, R6, R7 and W have the meanings indicated in claim 1 and R8 represents formula (4) with a formula c (5): R2-XL where: R2 and X they have the meaning indicated in the
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19835950A DE19835950A1 (en) | 1998-08-08 | 1998-08-08 | Piperazinone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020124A1 true AR020124A1 (en) | 2002-04-10 |
Family
ID=7876912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103925A AR020124A1 (en) | 1998-08-08 | 1999-08-06 | DERIVATIVES OF PIPERAZINONE, A PROCEDURE FOR THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR020124A1 (en) |
AU (1) | AU5411499A (en) |
DE (1) | DE19835950A1 (en) |
WO (1) | WO2000008005A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE346050T1 (en) * | 1998-01-27 | 2006-12-15 | Aventis Pharma Inc | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR XA INHIBITORS |
CA2422873A1 (en) * | 2000-09-29 | 2002-04-04 | Wenhao Li | Piperazin-2-one amides as inhibitors of factor xa |
AU2003282566A1 (en) * | 2002-10-09 | 2004-05-04 | Millennium Pharmaceuticals, Inc. | Piperazine and piperazinone inhibitors of factor xa |
CN100513398C (en) | 2002-12-03 | 2009-07-15 | Axys药物公司 | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4302485A1 (en) * | 1993-01-29 | 1994-08-04 | Merck Patent Gmbh | Piperazine derivatives |
EP0623615B1 (en) * | 1993-05-01 | 1999-06-30 | MERCK PATENT GmbH | Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
DE19530996A1 (en) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclic guanidines, process for their preparation and pharmaceuticals |
EP0765660A3 (en) * | 1995-09-28 | 1998-09-23 | Takeda Chemical Industries, Ltd. | Microcapsules comprising 2-piperazinone-1-acetic acid compounds |
AU4172397A (en) * | 1996-09-06 | 1998-03-26 | Biochem Pharma Inc. | Lactam inhibitors of thrombin |
-
1998
- 1998-08-08 DE DE19835950A patent/DE19835950A1/en not_active Withdrawn
-
1999
- 1999-07-16 AU AU54114/99A patent/AU5411499A/en not_active Abandoned
- 1999-07-16 WO PCT/EP1999/005070 patent/WO2000008005A2/en active Application Filing
- 1999-08-06 AR ARP990103925A patent/AR020124A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000008005A3 (en) | 2000-05-18 |
DE19835950A1 (en) | 2000-02-10 |
AU5411499A (en) | 2000-02-28 |
WO2000008005A2 (en) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR010932A1 (en) | DERIVATIVES OF PIPERAZINE, A PROCEDURE TO PREPARE THEM, THE USE OF THE SAME IN THE PREPARATION OF MEDICINES, THE PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM AND A PROCEDURE TO DEVELOP THESE PHARMACEUTICAL PREPARATIONS. | |
AR019777A1 (en) | DERIVATIVES OF DIACIL HYDRAZINE, A PROCEDURE FOR THEIR PREPARATION, THE USE OF THE SAME IN THE PREPARATION OF MEDICINES, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND A PROCEDURE TO PREPARE THESE PHARMACEUTICAL COMPOSITIONS | |
AR037743A1 (en) | TYPE 4 PHOSPHODESTERASE INHIBITORS, COMBINATIONS AND USES OF THE SAME | |
AR043477A1 (en) | AROMATIC BICYCLE COMPOUNDS REPLACED WITH AMINO-RENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CL2023001476A1 (en) | New antiviral agents derived from spiropyrrolidine | |
AR088808A2 (en) | DERIVATIVES OF 2H-PIRIDAZIN-3-ONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND A PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | |
AR030432A1 (en) | USE OF QUINAZOLINE DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT TO BE USED IN THE INHIBITION OF AURORA QUINASA2, RELATED COMPOUNDS, AND PHARMACEUTICAL COMPOSITION. | |
AR049662A1 (en) | 1,3-PHENYLENDIAMINE DERIVATIVES WITH INHIBITORY EFFECT OF B-RAF; A METHOD FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF CANCER | |
AR049103A1 (en) | PIRIDAZINONE DERIVATIVES METHODS FOR PRODUCERS AND THEIR USE AS PHARMACEUTICAL PRODUCTS | |
AR053992A1 (en) | CHEMICAL COMPOUNDS WITH ANTI-TARGET ACTIVITY, A PROCEDURE FOR THEIR PREPARATION, ITS USE IN THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITION. | |
AR039933A1 (en) | INDOLES REPLACED FOR TREATMENT OF RESPIRATORY DISORDERS | |
AR036045A1 (en) | AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, ITS EMPLOYMENT FOR THE PREPARATION OF A MEDICINAL PRODUCT, AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR040700A1 (en) | PIRIMIDILSULFONAMIDE DERIVATIVES AS CHEMIOKIN RECEPTORS MODULATORS | |
AR050261A2 (en) | AMINO ACIDS AFFECTED BY THE ALFA-2-DELTA PROTEIN AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE TO PREPARE A MEDICINAL PRODUCT | |
AR035325A1 (en) | ADAMANTAN DERIVATIVES, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, A PROCESS FOR THE PREPARATION OF SUCH COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
FI951966A (en) | New polyene compounds, pharmaceutical and cosmetic compositions containing them and their use | |
AR047987A1 (en) | DERIVATIVES OF 4-BENCIMIDAZOL-2-IL-PIRIDAZIN-3-ONA | |
AR046086A1 (en) | DERIVATIVES OF 1,3- BENZOXAZOLILO AS QUINASA INHIBITORS | |
HUP0104164A2 (en) | Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation | |
AR020124A1 (en) | DERIVATIVES OF PIPERAZINONE, A PROCEDURE FOR THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME TO PREPARE A MEDICINAL PRODUCT | |
AR041340A1 (en) | DERIVATIVES OF THIAZOLPIRIMIDINONE, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR035196A1 (en) | GUANIDINE OR BIGUANIDINE DERIVATIVES AND THE USE OF THE SAME FOR THE MANUFACTURE OF ANTIVIRAL AND ANTIMICROBIAL DRUGS | |
AR058398A1 (en) | DIAZEPINONES, PROCESSES OF OBTAINING, PHARMACEUTICAL COMPOSITIONS AND ITS USE AS INHIBITORS OF KINASES. | |
AR039658A1 (en) | TRIARIL-OXI-ARILOXI-PIRIMIDIN-2,4,6-TRIONA METALOPROTEINASE INHIBITORS | |
ATE206116T1 (en) | 6-CARBOXAMIDO-DIHYDROPYRAN DERIVATIVES |